Join
Live feed
·
PRReleasevia Quantisnow
Magenta Therapeutics Inc. logo

Magenta Therapeutics Voluntarily Pauses the MGTA-117 Phase 1/2 Dose-Escalation Clinical Trial to Investigate Drug Safety

ByQuantisnow·Wall Street's wire, on your screen.
MGTA· Magenta Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track MGTA (Magenta Therapeutics Inc.) and more on Quantisnow.